文献速递创伤骨科

由教练提供的以患者为中心的教育和疼痛管理能否改善骨科创伤后的疼痛结局?一项随机试验

Can Patient-centered Education and Pain Management Delivered by Coaches Improve Pain Outcomes After Orthopaedic Trauma? A Randomized Trial.
PubMed 文献 · Clin Orthop Relat Res · 2024-05-15

该随机试验将212例骨科创伤患者分为由辅助专业教练提供的个性化疼痛教育与管理干预组和常规书面出院指导对照组,比较12周疼痛评分、阿片类药物用量及PROMIS评分。结果显示两组在平均疼痛评分、达到最小临床重要差异的比例、阿片类药物用量及PROMIS各项评分上均无差异。

要点

  • 教练主导的个性化疼痛教育未改善12周平均疼痛评分。
  • 两组阿片类药物用量(住院期间、出院时及处方续配)无差异。
  • 两组PROMIS身体功能、疼痛干扰、睡眠障碍达到MCID的比例均无差异。

核心结论

  • 在本试验中,干预组与对照组在骨科创伤后的疼痛结局、阿片类药物使用或患者报告结局方面均无差异。
  • 作者认为,未来需要在术后不良结局风险增加的不同患者样本中开展针对性研究,以确定与教练合作对疼痛结局可能存在的有意义的患者感知效果。
  • 作者建议,其他对此干预方法感兴趣的研究者可将教练项目作为其机构的框架,以增加术后疼痛结局不良风险增加的患者获得循证非药物干预的机会。
  • 作者认为,更小型、更聚焦的连接患者与教练学习非药物疼痛管理干预的项目可能对患者康复和结局产生更大影响。

研究设计与样本

  • 随机临床试验,比较由辅助专业教练提供的个性化疼痛教育与管理干预与常规护理(关于疼痛管理和阿片类药物安全的书面出院指导)。
  • 2021年2月至2022年9月期间,212例患者随机分为干预组(49%[104例])或对照组(51%[108例])。
  • 干预组中31%(104例中32例)和对照组中47%(108例中51例)在最低12周研究随访前失访或数据集不完整,最终干预组69%(104例中72例)和对照组53%(108例中57例)纳入分析。
  • 最终样本129例中,多数参与者自我认同为黑人(73%[129例中94例])和女性(56%[129例中72例]),平均损伤严重度评分为8±4,三分之一参与者根据阿片类药物风险工具处于阿片类药物使用障碍中至高危。
  • 证据等级:I级,治疗性研究。

主要发现

  • 干预组与对照组12周平均疼痛评分无差异。
  • 达到24小时平均疼痛评分2分MCID的患者比例在干预组为85%(72例中61例),对照组为72%(57例中41例),OR 2.2(95%CI 0.9至5.3),p=0.08。
  • 住院期间、出院时或处方续配的每日吗啡毫克当量在干预组与对照组之间无差异。
  • 达到PROMIS身体功能MCID的患者比例在干预组为81%(72例中58例),对照组为63%(57例中36例),OR 2.2(95%CI 0.9至5.2),p=0.06。
  • 达到PROMIS睡眠障碍MCID的患者比例在干预组为58%(72例中42例),对照组为47%(57例中27例),OR 1.4(95%CI 0.7至3.0),p=0.31;达到PROMIS疼痛干扰MCID的患者比例在干预组为39%(72例中28例),对照组为37%(57例中21例),OR 1.1(95%CI 0.5至2.1),p=0.95。

关键数值与推荐

  • 疼痛数值评定量表(0至10分)评估过去24小时平均疼痛强度,MCID为2分。
  • PROMIS身体功能、疼痛干扰、睡眠障碍的MCID按原文所用标准判定。
  • 阿片类药物使用以每日吗啡毫克当量衡量,数据来自电子健康记录。

临床怎么用

  • 作者建议,其他对此干预方法感兴趣的研究者可将教练项目作为其机构的框架,以增加术后疼痛结局不良风险增加的患者获得循证非药物干预的机会。
  • 作者认为,更小型、更聚焦的连接患者与教练学习非药物疼痛管理干预的项目可能对患者康复和结局产生更大影响。

局限性

  • 干预组31%(104例中32例)和对照组47%(108例中51例)在最低12周研究随访前失访或数据集不完整,最终干预组69%(104例中72例)和对照组53%(108例中57例)纳入分析。
  • 作者认为,未来需要在术后不良结局风险增加的不同患者样本中开展针对性研究,以确定与教练合作对疼痛结局可能存在的有意义的患者感知效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pain after orthopaedic trauma is complex, and many patients who have experienced orthopaedic trauma are at increased risk for prolonged opioid utilization after the injury. Patient-centered interventions capable of delivering enhanced education and opioid-sparing pain management approaches must be implemented and evaluated in trauma care settings to improve pain outcomes and minimize opioid-related risks. QUESTIONS/PURPOSES: Does personalized pain education and management delivered by coaches (1) improve pain-related outcomes, (2) reduce opioid consumption, and (3) improve patient-reported outcome measures (Patient-Reported Outcomes Measurement Information System [PROMIS] scores) compared to written discharge instructions on pain management and opioid safety? METHODS: This clinical trial aimed to examine the effect of a personalized pain education and management intervention, delivered by paraprofessional coaches, on pain-related outcomes and opioid consumption compared with usual care (written discharge instructions on pain management and opioid safety). Between February 2021 and September 2022, 212 patients were randomized to the intervention (49% [104]) or control group (51% [108]). A total of 31% (32 of 104) and 47% (51 of 108) in those groups, respectively, were lost before the minimum study follow-up of 12 weeks or had incomplete datasets, leaving 69% (72 of 104) and 53% (57 of 108) for analysis in the intervention and control group, respectively. Patients randomized to the intervention worked with the paraprofessional coaches throughout hospitalization after their orthopaedic injury and at their 2-, 6-, and 12-week visits with the surgical team after discharge to implement mindfulness-based practices and nonpharmacological interventions. Most participants in the final sample of 129 identified as Black (73% [94 of 129]) and women (56% [72 of 129]), the mean Injury Severity score was 8 ± 4, and one-third of participants were at medium to high risk for an opioid-use disorder based on the Opioid Risk Tool. Participants completed surveys during hospitalization and at the 2-, 6-, and 12-week follow-up visits. Surveys included average pain intensity scores over the past 24 hours measured on the pain numeric rating scale from 0 to 10 and PROMIS measures (physical functioning, pain interference, sleep disturbance). Opioid utilization, measured as daily morphine milligram equivalents, was collected from the electronic health record, and demographic and clinical characteristics were collected from self-report surveys. Groups were compared in terms of mean pain scores at the 12-week follow-up, daily morphine milligram equivalents both during inpatient and at discharge, and mean PROMIS scores at 12 weeks of follow-up. Additionally, differences in the proportion of participants in each group achieving minimum clinically important differences (MCID) on pain and PROMIS scores were examined. For pain scores, an MCID of 2 points on the pain numeric rating scale assessing past 24-hour pain intensity was utilized. RESULTS: We found no difference between the intervention and control in terms of mean pain score at 12 weeks nor in the proportions of patients who achieved the MCID of 2 points for 24-hour average pain scores (85% [61 of 72] versus 72% [41 of 57], respectively, OR 2.2 [95% confidence interval (CI) 0.9 to 5.3]; p = 0.08). No differences were noted in daily morphine milligram equivalents utilized between the intervention and control groups during hospitalization, at discharge, or in prescription refills. Similarly, we observed no differences in the proportions of patients in the intervention and control groups who achieved the MCID on PROMIS Physical Function (81% [58 of 72] versus 63% [36 of 57], respectively, OR 2.2 [95% CI 0.9 to 5.2]; p = 0.06). We saw no differences in the proportions of patients who achieved the MCID on PROMIS Sleep Disturbance between the intervention and control groups (58% [42 of 72] versus 47% [27 of 57], respectively, OR 1.4 [95% CI 0.7 to 3.0]; p = 0.31). The proportion of patients who achieved the MCID on PROMIS Pain Interference scores did not differ between the intervention and the control groups (39% [28 of 72] versus 37% [21 of 57], respectively, OR 1.1 [95% CI 0.5 to 2.1]; p = 0.95). CONCLUSION: In this trial, we observed no differences between the intervention and control groups in terms of pain outcomes, opioid medication utilization, or patient-reported outcomes after orthopaedic trauma. However, future targeted research with diverse samples of patients at increased risk for poor postoperative outcomes is warranted to ascertain a potentially meaningful patient perceived effect on pain outcomes after working with coaches. Other investigators interested in this interventional approach may consider the coach program as a framework at their institutions to increase access to evidence-based nonpharmacological interventions among patients who are at increased risk for poor postoperative pain outcomes. Smaller, more focused programs connecting patients to coaches to learn about nonpharmacological pain management interventions may deliver a larger impact on patient's recovery and outcomes. LEVEL OF EVIDENCE: Level I, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Giordano NA, Und Aspang JS, Baker J, et al. Can Patient-centered Education and Pain Management Delivered by Coaches Improve Pain Outcomes After Orthopaedic Trauma? A Randomized Trial. Clin Orthop Relat Res. 2024. PMID: 38843502. doi:10.1097/CORR.0000000000003121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。